Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

9.1%

2 terminated/withdrawn out of 22 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

23%

5 trials in Phase 3/4

Results Transparency

25%

4 of 16 completed trials have results

Key Signals

1 recruiting4 with results

Enrollment Performance

Analytics

Phase 2
8(40.0%)
Phase 1
6(30.0%)
Phase 3
3(15.0%)
Phase 4
2(10.0%)
N/A
1(5.0%)
20Total
Phase 2(8)
Phase 1(6)
Phase 3(3)
Phase 4(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (22)

Showing 20 of 22 trials
NCT07553065Phase 2Not Yet Recruiting

RELIEVE Study: NT 201 Intravesical Administration Using Vibe System (ViXe Combination Product) for the Treatment of Idiopathic Overactive Bladder

Role: collaborator

NCT06690710Phase 1Recruiting

FiH Safety and Feasibility Study Assessing Intra-articular Administration of aeGF in Patients With Knee Osteoarthritis

Role: collaborator

NCT07017114Phase 1Completed

Pentoxifylline PKB171 Gel in Healthy Females Volunteers

Role: collaborator

NCT05357989Phase 3Completed

A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD

Role: collaborator

NCT03591887Phase 2Completed

A Study to Evaluate ABY-035 in Subjects With Moderate-to-severe Plaque Psoriasis

Role: collaborator

NCT05222724Phase 4Completed

Efficacy of the Combination of Ibuprofen and Paracetamol in Acute Non-specific Low Back Pain

Role: collaborator

NCT02432846Phase 2Completed

Intratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post-nephrectomy in Newly Diagnosed Metastatic Renal Cell Carcinoma (mRCC)

Role: collaborator

NCT04778176Phase 2Completed

Assessing the Pharmacokinetics, Safety, Tolerability and Efficacy of Continuous Oral Levodopa Via the DopaFuse® Delivery System in Parkinson's Disease Patients

Role: collaborator

NCT04247256Phase 1Unknown

A Phase 2 Trial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRI

Role: collaborator

NCT02789137Completed

Study On Fatigue- And Hand-Foot Syndrome-Related Quality Of Life In Patients With Metastatic Renal Cell Carcinoma Receiving A Tyrosine Kinase Inhibitor as First-Line Treatment

Role: collaborator

NCT01552707Phase 1Completed

Safety Study of Mesenchymal Stem Cells and Spinal Fusion

Role: collaborator

NCT00485017Phase 2Completed

Efficacy and Safety of THR-4109 in Obese Subjects

Role: collaborator

NCT01896284Phase 4Completed

Study to Evaluate Efficacy of Aflibercept in Neovascular Age-related Macular Degeneration Patients Non Responders to Anti-Vascular Endothelial Growth Factor

Role: collaborator

NCT01288339Phase 2Completed

Study Assessing Potential Predictive Tumor Markers in Metastatic Colorectal Cancer

Role: collaborator

NCT02335723Not ApplicableTerminated

ASSET - a Double-Blind, Randomized Placebo-Controlled Clinical Investigation With Alteco® LPS Adsorber

Role: collaborator

NCT01237249Phase 2Completed

Study of Treatment for Newly Diagnosed Multiple Myeloma Patients Older Than 65 Years With Sequential Melphalan/Prednisone/Velcade (MPV) Followed by Revlimid/Low Dose Dexamethasone (Rd) Versus Alternating Velcade/Melphalan/Prednisone (MPV) With Revlimid/Low Dose Dexamethasone

Role: collaborator

NCT01977443Phase 2Completed

Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC)

Role: collaborator

NCT01951924Phase 3Completed

LIME Study (LFB IVIg MMN Efficacy Study)

Role: collaborator

NCT02448914Phase 1Completed

A Study to Compare Plasma Levels of Levodopa, Carbidopa and Entacapone After TRIGEL or Duodopa Infusion in PD Patients

Role: collaborator

NCT01562951Phase 3Terminated

Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants

Role: collaborator